Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide

British Journal of Pharmacology

Volumn 125, Issue 8, 1998, Pages 1695-1707

  Weisbrod, Robert M ^a   Griswold, Mark C ^a   Yaghoubi, Mohammad ^a   Komalavilas, Padmini ^b   Lincoln, Thomas M ^b   Cohen, Richard A ^a,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

Calcium; Cyclic GMP; Nitric oxide; Protein kinase G; Smooth muscle

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC GMP; ANGIOTENSIN; CALCIUM ION; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; FURA 2; MEMBRANE RECEPTOR; NITRIC OXIDE; ZAPRINAST;

ANIMAL TISSUE; AORTA MEDIA; ARTERY DILATATION; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; FLUOROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RABBIT; RADIOIMMUNOASSAY;

1-METHYL-3-ISOBUTYLXANTHINE; 3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANGIOTENSIN II; ANIMALS; AORTA; CALCIUM; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GUANYLATE CYCLASE; MANGANESE; MUSCLE RELAXATION; MUSCLE, SMOOTH; NITRIC OXIDE; OXADIAZOLES; PHOSPHODIESTERASE INHIBITORS; PROTEIN KINASE C; PURINONES; QUINOXALINES; RABBITS; THIONUCLEOTIDES; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0032420208     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702233     Document Type: Article

References (44)

1. ARCHER, S.L., HUANG, J.M.C., HAMPL, V., NELSON, D.P., SHULTZ, P.J. & WEIR, E.K. (1994). Nitric oxide and cGMP cause vasorelaxation by cGMP-kinase-dependent activation of a charybdotoxin-sensitive K channel. Proc. Natl. Acad. Sci. U.S.A., 91, 7583-7587.
2. BELTMAN, J., SONNENBURG, W.K. & BBAVO, J.A. (1993). The role of protein phosphorylation in the regulation of cyclic nucleotide phosphodiesterases. Mol. Cell. Biochem., 127/128, 239-253.
3. BIEL, M., ZONG, X., DISTLER, M., BOSSE, E., KLUGBAUER, N., MURAKAMI, M., FLOCKERZI, V. & HOFMANN, F. (1994).Another member of the cyclic nucleotide-gated channel family, expressed in testis, kidney, and heart. Proc. Natl. Acad. Sci. U.S.A., 91, 3505-3509.
4. 2+], in vascular smooth muscle by inhibition of calcium current. Cell, Calcium., 15, 122-131.
5. BOLOTINA, V.M., NAJIBI, S., PALACINO, J.J., PAGANO, P.J. & COHEN, R.A. (1994). Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle cells. Nature. 368, 850-853.
6. BOLOTINA, V.M., WEISBROD, R.M. GERICKE, M., TAYLOR, P. & COHEN, R.A. (1997). Novel store-operated cation channels mediate agonist-induced calcium influx and contraction in rabbit aortic smooth muscle cells. Biophys J., 72, A336.
7. BRUNNER, F., SCHMIDT, K., NIELSEN, E.B. & MAYER, B. (1996). Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery. J. Pharmacol. Exp. Ther., 277, 48-53.
8. BUTT, E., VAN BEMMELEN, M., FISCHER, L., WALTER, U. & JASTORFE, B. (1990). Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3′,5′-monophosphorothioates. FEBS. Letters, 263, 47-50.
9. i, and arterial smooth muscle relaxation. Am. J. Physiol., 263, C468-C473.
10. COHEN, R.A., PLANE, F., NAJIBI, S., HUK, I., MALINSKI, T. & GARLAND, C.J. (1997). Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery. Proc. Natl. Acad. Sci. U.S.A., 94, 4193-4198.
11. CORBIN, J.D., OGREID, D., MILLER, J.P., SUVA, R.H., JASTORFF, B. & DOSKELAND, S.Q. (1986). Studies of cGMP analog specificity and function of the two intrasubunit binding sites of cGMP-dependent protein kinase. J. Biol. Chem., 261, 1208-1214.
12. CORNWELL, T.L., PRYZWANSKY, K.B., WYATT, T.A. & LINCOLN, T.M. (1991). Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells. Mol. Pharmacol., 40, 923-931.
13. COWAN, C.L., PALACINO, J.J., NAJIBI, S. & COHEN, R.A. (1993). Potassium channel mediated relaxation to acetylcholine in rabbit arteries. J. Pharmacol. Exp. Ther., 266, 1482-1489.
14. ECKLY-MICHEL, A., MARTIN, V. & LUGNIER, C. (1997). Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation. Br. J. Pharmacol., 122, 158-164.
15. 2+ exchange in vascular smooth muscle cells in primary culture. J. Biol. Chem., 266, 12337-12341.
16. 2+ pump by cyclic nucleotides in cultured vascular smooth muscle cells. J. Biol. Chem., 263, 8058-8065.
17. GARTHWAITE, J., SOUTHAM, E., BOULTON, C.L., NIELSEN, E.B., SCHMIDT, K. & MAYER, B. (1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol., 48, 184-188.
18. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3340-3450.
19. + -ATPase activity by nitric oxide: a cGMP-independent effect. Am. J. Physiol., 266, H2146-H2151.
20. HIRATA, M., KOHSE, K.P., CHANG, C.-H., IKEBE, T. & MURAD, F. (1990). Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J. Biol. Chem., 265, 1268-1273.
21. IGNARRO, L.J. & KADOWITZ, P.J. (1985). The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Ann. Rev. Pharmacol. Toxicol., 25, 171-191.
22. KOGA, T., YOSHIDA, Y., CAI, J.Q., ISLAM, M.O. & IMAI, S. (1994). Purification and characterization of 240-kDa cGMP-dependent protein kinase substrate of vascular smooth muscle: close resemblance to inositol 1,4,5-triphosphate receptor. J. Biol. Chem., 269, 11640-11647.
23. KOMALAVILAS, P. & LINCOLN, T.M. (1994). Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic GMP-dependent protein kinase. J. Biol. Chem., 269, 8701-8707.
24. KOMALAVILAS, P. & LINCOLN, T.M. (1996). Phosphorylation of the inositol 1,4,5-trisphosphate receptor: cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta. J. Biol. Chem., 271, 21933-21938.
25. Ca channel activity in coronary artery smooth muscle. Hypertension, 31, 303-308.
26. LINCOLN, T.M., CORNWELL, T.L., KOMALAVILAS, P., MACMILLAN-CROW, L.A. & BOERTH, N. (1996). The nitric oxide-cyclic GMP signaling system. In: Biochemistry of Smooth Muscle Contraction, pp. 257-268. (ed). Barany, M. New York, N.Y.: Academic Press, Inc.
27. MALINSKI, T., TAHA, Z., GRUNFELD, S., PATTON, S., KAPTURCZAK, M. & TOMBOULIAN, P. (1993). Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors. Biochem. Biophys. Res. Commun., 193, 1076-1082.
28. i and uncoupling stress from myosin phosphorylation. Am. J. Physiol., 263, C461-C467.
29. MORO, M.A., RUSSELL, R.J., CELLEK, S., LIZASOAIN, I., SU, Y., DARLEY-USMAR, V.M., RADOMSKI, M.W. & MONCADA, S. (1996). cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. U.S.A., 93, 1480-1485.
30. MURTHY, K.S. & MAKHLOUF, G.M. (1995). Interaction of cA-kinase and Cg-kinase in mediating relaxation of dispersed smooth muscle cells. Am. J. Physiol., 268, C171-C180.
31. OLSON, L.J., KNYCH, J.R. HERZIG, T.C. & DREWETT, J.G. (1997). Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation. Hypertension, 29, 254-261.
32. PLANE, F., WILEY, K.E., JEREMY, J.Y., COHEN, R.A. & GARLAND, C.J. (1998). Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery. Br. J. Pharmacol., 123, 1351-1358.
33. QUIGNARD, J.F., FRAPIER, J.M., HARRICANE, M.C., ALBAT, B., NARGEOT, J. & RICHARDS, S. (1997). Voltage-gated calcium channel currents in human coronary myocytes. J. Clin. Invest., 99, 185-193.
34. RAEYMAEKERS, L., HOFMANN, F. & CASTEELS, R. (1988). Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle. Biochem. J., 252, 269-273.
35. RAPOPORT, R.M. (1986). Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidylinositol hydrolysis in rat aorta. Circ. Res., 58, 407-410.
36. ROBERTSON, B.E., SCHUBERT, R., HESCHELER, J. & NELSON, M.T. (1993). cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am. J. Physiol., 265, C299-C303.
37. RUTH, P., WANG, G.X., BOEKHOFF, I., MAY, B., PFEIFER, A., PENNER, R., KORTH, M., BREER, H. & HOFFMAN, F. (1993). Transfected cGMP-dependent protein kinase suppresses calcium transients by inhibition of inositol 1,4,5-trisphosphate production. Proc. Natl. Acad. Sci. U.S.A., 90, 2623-2627.
38. SADEGHI-HASHJIN, G., FOLKERTS, G., HENRICKS, P.A.J., VAN DE LOO, P.G.F., DIK, I.E.M. & NAJKAMP, F.P. (1996). Relaxation of guinea-pig trachea by sodium nitroprusside: cyclic GMP and nitric oxide not involved. Br. J. Pharmacol., 118, 466-470.
39. SCHOEFFTER, P., LUGNIER, C., DEMESY-WAELDELE, F. & STOCLET, J.C. (1988). Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. Biochem. Pharmacol., 36, 3965-3972.
40. SMITH, J.B. & LINCOLN, T.M. (1987). Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor. Am. J. Physiol., 253, C147-C150.
41. + channels are stimulated by cyclic guanosine monophosphate-dependent protein kinase in canine coronary artery smooth muscle cells. Pflugers. Arch. Eur. J. Physiol., 423, 167-172.
42. WALDMAN, S.A. &MURAD, F. (1987). Cyclic GMP synthesis and function. Pharmacol. Rev., 39, 163-196.
43. WEISBROD, R.M., GRISWOLD, M.C., DU, Y., BOLOTINA, V.M. & COHEN, R.A. (1997). Reduced responsiveness of hypercholesterolemic rabbit aortic smooth muscle cells to nitric oxide. Arterioscler. Thromb. Vasc. Biol., 17, 394-402.
44. + channels in vascular smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A., 85, 9360-9364.